Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

848
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
848
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The role of Spanish clinical pharmacologists in economic evaluations of health technologies.

European journal of clinical pharmacology·2026
Same author

Do conditional marketing authorisations actually accelerate patient access? Time-to-access of conditional vs. standard marketing authorisations in Italy, Spain, and Germany.

Journal of pharmaceutical policy and practice·2026
Same author

Availability of pharmacological treatments for multiple myeloma in Spain.

The European journal of health economics : HEPAC : health economics in prevention and care·2026
Same author

Update on the Prevalence, Incidence, Mortality, and Trends in Treatment of Inflammatory Bowel Disease in a Population-Based Registry in Catalonia Between 2017 and 2023.

Journal of clinical medicine·2025
Same author

Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2025
Same author

A 25-Year Retrospective of Health IT Infrastructure Building: The Example of the Catalonia Region.

Journal of medical Internet research·2024

Video Experimental Relacionado

Updated: Jan 8, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K

Ensayos clínicos de baja intervención en España: ¿progresan?

Claudia Erika Delgado-Espinoza1,2,3, Mayro J Cortés Pestana1,2,3, Kristopher Amaro1,2,3

  • 1Department of Pharmacology and Therapeutics, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

British journal of clinical pharmacology
|December 17, 2025
PubMed
Resumen

Los Ensayos Clínicos de Baja Intervención (ECBI) siguen siendo una pequeña fracción de los estudios en España, principalmente no comerciales y que evalúan medicamentos autorizados. Sus diseños podrían ser más robustos, pero los cambios regulatorios recientes no muestran impacto en la actividad de los ECBI.

Palabras clave:
ensayos clínicosensayos clínicos de baja intervencióninvestigación clínica no comercialregulación

Más Videos Relacionados

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.7K
Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.5K

Videos de Experimentos Relacionados

Last Updated: Jan 8, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.1K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.7K
Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.5K

Área de la Ciencia:

  • Farmacología clínica
  • Ciencia regulatoria
  • Investigación en servicios de salud

Sus antecedentes:

  • Los Ensayos Clínicos de Baja Intervención (ECBI) son estudios pragmáticos de medicamentos autorizados.
  • Se introdujeron regulaciones simplificadas en 2014 para apoyar los ensayos clínicos no comerciales (ECNC).
  • La implementación del Sistema de Información de Ensayos Clínicos (CTIS) en 2023 puede afectar la viabilidad de los ECBI.

Objetivo del estudio:

  • Describir las características de los ECBI aprobados en España entre 2014 y 2023.
  • Evaluar el impacto de los cambios regulatorios y de CTIS en los ECBI.

Principales métodos:

  • Análisis descriptivo transversal de los ECBI.
  • Datos obtenidos del Registro Español de Estudios Clínicos (REec) (2014-2023).

Principales resultados:

  • Los ECBI representaron el 3,8 % (322/8497) de todos los ensayos registrados.
  • La mayoría de los ECBI fueron patrocinados de forma no comercial, de fase IV, monocéntricos y evaluaron medicamentos autorizados.
  • La eficacia/seguridad fueron los objetivos principales; la farmacoeconomía y la bioequivalencia fueron menos comunes.
  • Los diseños a menudo fueron aleatorizados pero raramente ciegos o controlados con placebo.

Conclusiones:

  • Los ECBI son cruciales para la evidencia del mundo real, pero siguen siendo una pequeña proporción de los ensayos en España.
  • Los diseños de los ECBI tienen margen de mejora en cuanto a robustez.
  • La implementación de CTIS no pareció afectar la actividad de los ECBI en 2023.